MicroPort NeuroScientific Corporation (HKG:2172)

Market Cap	6.72B
Revenue (ttm)	810.65M
Net Income (ttm)	270.48M
Shares Out	577.30M
EPS (ttm)	0.47
PE Ratio	24.92
Forward PE	19.77
Dividend	0.22 (1.90%)
Ex-Dividend Date	Jul 2, 2025

Volume	4,872,000
Average Volume	9,059,624
Open	11.60
Previous Close	11.64
Day's Range	10.92 - 11.60
52-Week Range	6.21 - 15.24
Beta	-0.10
RSI	49.48
Earnings Date	Mar 28, 2025

About MicroPort NeuroScientific

MicroPort NeuroScientific Corporation engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally. The company offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; NUMEN Silk; Tubridge, a flow-diverting stent; Willis, an intracranial stent graft system; Comaneci, an adjustable temporary coil embolization; and Rebridge, an intracranial visualized stent for use in the treatment of hemorrhagic stroke. It also offers NeuroGuard, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 527
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2172

Financial Performance

In 2024, MicroPort NeuroScientific's revenue was 761.76 million, an increase of 14.44% compared to the previous year's 665.62 million. Earnings were 254.17 million, an increase of 74.63%.

Financial numbers in CNY